Concentration (mg/ml)
|
C. aurantifolia
|
A. nobilis
|
L. officinalis
|
---|
50
|
100.0 ± 0.0a,b
|
99.0 ± 0.38a,b
|
100.0 ± 0.0a,b
|
25
|
100.0 ± 0.0a,b
|
99.4 ± 0.87a,b
|
100.0 ± 0.0a,b
|
12.5
|
98.9 ± 1.87a,b
|
97.0 ± 2.38a,b
|
99.8 ± 0.30a,b
|
6.25
|
96.4 ± 2.61a,b
|
95.7 ± 2.13a,b
|
99.4 ± 0.94a,b
|
3.125
|
95.9 ± 2.41a,b
|
86.4 ± 4.71b
|
92.3 ± 3.03b
|
1.562
|
86.9 ± 2.33b
|
74.5 ± 3.58b
|
82.8 ± 3.62b
|
0.781
|
56.2 ± 3.97b
|
63.3 ± 4.12b
|
85.0 ± 3.15b
|
0.390
|
42.1 ± 4.70b
|
26.6 ± 1.46b
|
81.8 ± 1.36b
|
0.195
|
14.9 ± 3.89b
|
13.4 ± 2.33b
|
9.5 ± 1.54b
|
0.097
|
13.0 ± 1.44b
|
14.1 ± 2.60b
|
6.8 ± 1.69
|
|
IC50 = 0.694 mg/ml
|
IC50 = 0.842 mg/ml
|
IC50 = 0.316 mg/ml
|
|
R2 = 0.985
|
R2 = 0.978
|
R2 = 0.950
|
Thiabendazol (0.025 mg/ml)
|
100.0 ± 0.0b
|
100.0 ± 0.0b
|
100.0 ± 0.0b
|
Tween 80 (3%)
|
7.6 ± 0.85
|
7.4 ± 3.94
|
3.5 ± 0.82
|
- Abbreviations: IC50, inhibitory concentration 50%; R2, nonlinear correlation coefficient
- aNo statistically significant difference between positive control and treatments
- bSignificant difference between positive control or treatments with negative control (ANOVA, followed by Tukey test; P < 0.05)